Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIFLUOX-DP: Trifluridine/Tipiracil in DPD Deficiency
NCT06245356Phase 2Recruiting
- Sponsor
- Unicancer
- Start
- Mar 2025
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trifluridine + tipiracil in metastatic colorectal cancer (mCRC), gastroesophageal adenocarcinoma, sponsored by Unicancer. Started Mar 2025; status: recruiting.
02
Drugs
trifluridine + tipiracil
03
Conditions
metastatic colorectal cancer (mCRC)gastroesophageal adenocarcinoma
Beyond the preview
Go deeper on NCT06245356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06245356.